High Throughput Screening Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers High Throughput Screening (HTS) Market Companies and the market is segmented by Technology (Ultra-high-throughput Screening, Cell-based Assays, Lab-on-a-chip and Label-free Technology), Application (Target Identification, Primary Screening, and Toxicology), Products and Services (Instruments, Reagents, and Kits, and Services), End User (Pharmaceutical and Biotechnology Firms, Academia and Research Institutes and Contract Research Organizations) and Geography (North America, Europe, Asia-Pacific, Middle-East, and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

High Throughput Screening Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

High-throughput Screening (HTS) Market Size

High-throughput Screening Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 7.80 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

High-throughput Screening Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global High-throughput Screening Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

High-throughput Screening (HTS) Market Analysis

The Global High-throughput Screening Market is expected to register a CAGR of 7.8% during the forecast period.

The emergence of the COVID-19 pandemic has had an adverse effect on the world economy and the healthcare system. There is a significant impact on the studied market. For instance, according to an article published in October 2021 titled 'Highthroughput screening assays for SARSCoV2 drug development: Current status and future directions, high-throughput screening has proven to be a useful approach for finding new lead compounds for the development of antiviral drugs. It has been observed that the autophagy and AP-1 signaling pathways may be promising targets for COVID-19 therapies through systematic mining of a sizable quantitative high-throughput screening (HTS) database. Thus, COVID-19 has impacted the market growth.

Certain factors that are propelling the market growth are open access to high-throughput screening laboratories, technological advancements in high-throughput screening, and increasing usage in universities and research centers.

Over the past few years, there has been a considerable growth in the number of high-throughput screening (HTS) facilities available to the public. These facilities range in size from modestly equipped university screening facilities to expansive molecular libraries and probe centers networks. These facilities provide a thorough method of probe discovery in academia and use both conventional and cutting-edge assay technology to carry out primary and secondary screening campaigns. One of the significant advantages of these centers was knowledge sharing among scientists, researchers, etc. For instance, the Columbia Genome Center offers high-quality molecular screening services for investigators throughout the Columbia University research community. Also, The European counterpart of the National Institutes of Health (NIH) program, known as EU-open-screen, provides open access to all European companies engaged in chemical biology. The association of high-throughput screening (HTS) centers is intended to provide useful information about the drug or target, or the entire process. Thus, open access provides a better platform for knowledge sharing and can help optimize the entire process, which may drive the demand for HTS technology among end users.

However, the high capital investment and need for extensive automation techniques are likely to hinder the market growth over the forecast period.

High-throughput Screening (HTS) Industry Overview

The high-throughput screening market is highly competitive and consists of several major players. Most of the major players enjoy a global presence and are facing intense competition in emerging economies. Emerging countries are becoming hotspots of significant competition, due to a rapidly expanding market size, fueled by growing investments in research and development and the recent trend of contract research outsourcing. Some of the key players in the market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Beckman Coulter Inc..

High-throughput Screening (HTS) Market Leaders

  1. Bio-Rad Laboratories Inc.

  2. PerkinElmer Inc.

  3. Thermo Fisher Scientific Inc.

  4. Merck KGaA

  5. Agilent Technologies Inc.

  6. *Disclaimer: Major Players sorted in no particular order
High-throughput Screening Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

High-throughput Screening (HTS) Market News

  • In August 2022, Molbio Diagnostics launched a new test for differential diagnosis of HIV 1 and HIV 2 with viral loads within 60 minutes.
  • In July 2022, Evotech Technologies launched the cell analyzer 'Opera' for fast high-content analysis of drug activity with sub-cellular resolution.
  • In February 2022, Bruker Corporation launched the timsTOF MALDI PharmaPulse (timsTOF MPP) system, a groundbreaking new high-end solution for unbiased, deep HTS and uHTS based on label-free mass spectrometry.

High-throughput Screening (HTS) Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Open Access to High-throughput Screening Laboratories
    • 4.2.2 Technological Advancements in HTS
    • 4.2.3 Increasing Usage in Universities and Research Centers
  • 4.3 Market Restraints
    • 4.3.1 High Capital Investment
    • 4.3.2 Need for Extensive Automation Techniques
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Ultra-high-throughput Screening
    • 5.1.2 Cell-based Assays
    • 5.1.3 Lab-on-a-chip
    • 5.1.4 Label-free Technology
  • 5.2 By Applications
    • 5.2.1 Target Identification
    • 5.2.2 Primary Screening
    • 5.2.3 Toxicology
  • 5.3 By Products and Services
    • 5.3.1 Instruments
    • 5.3.2 Reagents and Kits
    • 5.3.3 Services
  • 5.4 By End User
    • 5.4.1 Pharmaceutical and Biotechnology Firms
    • 5.4.2 Academia and Research Institutes
    • 5.4.3 Contract Research Organizations
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 Axxam SpA
    • 6.1.3 Beckman Coulter Inc.
    • 6.1.4 Bio-Rad Laboratories Inc.
    • 6.1.5 Danaher Corporation
    • 6.1.6 GE Healthcare
    • 6.1.7 Merck KGaA
    • 6.1.8 PerkinElmer Inc.
    • 6.1.9 Tecan Group Ltd
    • 6.1.10 Thermo Fisher Scientific Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

High-throughput Screening (HTS) Industry Segmentation

As per the scope of the report, high-throughput screening (HTS) is a technique for conducting scientific experiments that are particularly useful in the drug development process. HTS utilizes robotics liquid handlers, data processing, considerable software, and sensitive detection systems. The High-throughput Screening Market is segmented by Technology (Ultra-high-throughput Screening, Cell-based Assays, Lab-on-a-chip and Label-free Technology), Application (Target Identification, Primary Screening, and Toxicology), Products and Services (Instruments, Reagents, and Kits, and Services), End User (Pharmaceutical and Biotechnology Firms, Academia and Research Institutes and Contract Research Organizations) and Geography (North America, Europe, Asia-Pacific, Middle-East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Technology Ultra-high-throughput Screening
Cell-based Assays
Lab-on-a-chip
Label-free Technology
By Applications Target Identification
Primary Screening
Toxicology
By Products and Services Instruments
Reagents and Kits
Services
By End User Pharmaceutical and Biotechnology Firms
Academia and Research Institutes
Contract Research Organizations
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

High-throughput Screening (HTS) Market Research FAQs

What is the current Global High-throughput Screening Market size?

The Global High-throughput Screening Market is projected to register a CAGR of 7.8% during the forecast period (2025-2030)

Who are the key players in Global High-throughput Screening Market?

Bio-Rad Laboratories Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Merck KGaA and Agilent Technologies Inc. are the major companies operating in the Global High-throughput Screening Market.

Which is the fastest growing region in Global High-throughput Screening Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global High-throughput Screening Market?

In 2025, the North America accounts for the largest market share in Global High-throughput Screening Market.

What years does this Global High-throughput Screening Market cover?

The report covers the Global High-throughput Screening Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global High-throughput Screening Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

High Throughput Screening Industry Report

Statistics for the 2025 Global High-throughput Screening market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global High-throughput Screening analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.